244 related articles for article (PubMed ID: 30657565)
1. MiR-299-3p functions as a tumor suppressor in thyroid cancer by regulating SHOC2.
Chen X; Qi M; Yang Q; Li JY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):232-240. PubMed ID: 30657565
[TBL] [Abstract][Full Text] [Related]
2. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
[TBL] [Abstract][Full Text] [Related]
3. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1.
Yin JJ; Cheng XY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3431-3439. PubMed ID: 31081097
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles of circUBAP2 targeting miR-370-3p in proliferation, apoptosis, and invasion of papillary thyroid cancer cells.
Xiong H; Yu J; Jia G; Su Y; Zhang J; Xu Q; Sun X
Hum Cell; 2021 Nov; 34(6):1866-1877. PubMed ID: 34346032
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.
Guo F; Fu Q; Wang Y; Sui G
J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680
[TBL] [Abstract][Full Text] [Related]
7. METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
Lin S; Zhu Y; Ji C; Yu W; Zhang C; Tan L; Long M; Luo D; Peng X
J Clin Endocrinol Metab; 2022 Jan; 107(2):474-490. PubMed ID: 34562008
[TBL] [Abstract][Full Text] [Related]
8. Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma.
Wang L; Du ZG; Huang H; Li FS; Li GS; Xu SN
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10638-10646. PubMed ID: 31858530
[TBL] [Abstract][Full Text] [Related]
9. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.
Zheng J; Zhou Y; Li XJ; Hu JM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
Bai X; Xu Y; Liu Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
[TBL] [Abstract][Full Text] [Related]
11. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of long intergenic noncoding RNA LINC00312 inhibits the invasion and migration of thyroid cancer cells by down-regulating microRNA-197-3p.
Liu K; Huang W; Yan DQ; Luo Q; Min X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28539331
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LINC00488 facilitates thyroid cancer cell progression through miR-376a-3p/PON2.
Xie F; Li L; Luo Y; Chen R; Mei J
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33600548
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
Li P; Dong M; Wang Z
Bosn J Basic Med Sci; 2019 May; 19(2):146-154. PubMed ID: 30114378
[TBL] [Abstract][Full Text] [Related]
16. MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27.
Wang L; Wang Y; Lin J
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8789-8796. PubMed ID: 30575920
[TBL] [Abstract][Full Text] [Related]
17. MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer.
Bai D; Sun H; Wang X; Lou H; Zhang J; Wang X; Jiang L
Med Sci Monit; 2017 Oct; 23():4885-4894. PubMed ID: 29023429
[TBL] [Abstract][Full Text] [Related]
18. MiR-548b-3p inhibits proliferation and migration of breast cancer cells by targeting MDM2.
Sha MX; Huang XW; Yin Q
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3105-3112. PubMed ID: 32271428
[TBL] [Abstract][Full Text] [Related]
19. Circ_0000144 facilitates the progression of thyroid cancer via the miR-217/AKT3 pathway.
Fan YX; Shi HY; Hu YL; Jin XL
J Gene Med; 2020 Dec; 22(12):e3269. PubMed ID: 32890417
[TBL] [Abstract][Full Text] [Related]
20. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer.
Han Y; Kuang Y; Xue X; Guo X; Li P; Wang X; Guo X; Yuan B; Zhi Q; Zhao H
Biomed Pharmacother; 2014 Jun; 68(5):497-505. PubMed ID: 24972723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]